Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: Report of a case

J. H. Wang, J. H. Wang, Y. C. Liu, Y. S. Chen, M. Y. Yen, S. R. Wann, D. L. Cheng

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We report a 67-year-old male with pneumoniae in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration or oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromcyin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.

Original languageEnglish
Pages (from-to)642-644
Number of pages3
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume93
Issue number7
Publication statusPublished - 1994
Externally publishedYes

    Fingerprint

Keywords

  • azithromycin
  • Chlamydia pneumoniae

ASJC Scopus subject areas

  • Medicine(all)

Cite this